Evidence map›Paper›PMID 28628273›Full record

ArticleStem cells translational medicine2017

Exposure of Induced Pluripotent Stem Cell-Derived Vascular Endothelial and Smooth Muscle Cells in Coculture to Hemodynamics Induces Primary Vascular Cell-Like Phenotypes.

Maria S Collado, Banumathi K Cole, Robert A Figler, Mark Lawson, David Manka, Michael B Simmers, Steve Hoang, Felipe Serrano, Brett R Blackman, Sanjay Sinha and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  5. Using Genomics to Identify Novel Therapeutic Targets for Aortic Disease.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Human iPSC banking: barriers and opportunities.Journal of biomedical science · 2019
    Review
  20. Generation of Endothelial Cells From Human Pluripotent Stem Cells.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Maria S ColladoHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
Banumathi K ColeHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.ORCID 0000-0003-0976-2610
Robert A FiglerHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
Mark LawsonHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
David MankaHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
Michael B SimmersHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
Steve HoangHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
Felipe SerranoDepartment of Medicine and WT-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Brett R BlackmanHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
Sanjay SinhaDepartment of Medicine and WT-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Brian R WamhoffHemoShear Therapeutics, LLC, Charlottesville, Virginia, USA.
HemoShear (United States) · USWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Development of an iPSC-derived human vascular system for drug discovery and develR43TR001206 · NCATS · HEMOSHEAR THERAPEUTICS, LLC · PI WAMHOFF, BRIAN ROBERT · 2014 to 2014
$249k
British Heart Foundation FS/13/29/30024British Heart Foundation RG/17/5/32936Medical Research Council MC_PC_12009NCATS NIH HHS R43 TR001206
6 · The paper itself

Abstract

Human induced pluripotent stem cells (iPSCs) can be differentiated into vascular endothelial (iEC) and smooth muscle (iSMC) cells. However, because iECs and iSMCs are not derived from an intact blood vessel, they represent an immature phenotype. Hemodynamics and heterotypic cell:cell communication play important roles in vascular cell phenotypic modulation. Here we tested the hypothesis that hemodynamic exposure of iECs in coculture with iSMCs induces an in vivo-like phenotype. iECs and iSMCs were cocultured under vascular region-specific blood flow hemodynamics, and compared to hemodynamic cocultures of blood vessel-derived endothelial (pEC) and smooth muscle (pSMC) cells. Hemodynamic flow-induced gene expression positively correlated between pECs and iECs as well as pSMCs and iSMCs. While endothelial nitric oxide synthase 3 protein was lower in iECs than pECs, iECs were functionally mature as seen by acetylated-low-density lipoprotein (LDL) uptake. SMC contractile protein markers were also positively correlated between pSMCs and iSMCs. Exposure of iECs and pECs to atheroprone hemodynamics with oxidized-LDL induced an inflammatory response in both. Dysfunction of the transforming growth factor β (TGFβ) pathway is seen in several vascular diseases, and iECs and iSMCs exhibited a transcriptomic prolife similar to pECs and pSMCs, respectively, in their responses to LY2109761-mediated transforming growth factor β receptor I/II (TGFβRI/II) inhibition. Although there are differences between ECs and SMCs derived from iPSCs versus blood vessels, hemodynamic coculture restores a high degree of similarity in their responses to pathological stimuli associated with vascular diseases. Thus, iPSC-derived vascular cells exposed to hemodynamics may provide a viable system for modeling rare vascular diseases and testing new therapeutic approaches. Stem Cells Translational Medicine 2017;6:1673-1683.

Indexed as

Cell DifferentiationHemodynamicsPhenotypeTranscriptomeCells, CulturedCoculture TechniquesEndothelial CellsEndothelium, VascularHumansInduced Pluripotent Stem CellsMyocytes, Smooth MuscleReceptors, Transforming Growth Factor betaTransforming Growth Factor betaReceptors, Transforming Growth Factor betaTransforming Growth Factor betaEndothelial cellsHemodynamicsInduced pluripotent stem cellsSmooth muscle cellsVascular

Identifiers

PMID28628273
PMCPMC5689791
OpenAlexW2701956219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.